The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.

Abbott Laboratories (NYSE:ABT) was one of the stocks on which Jim Cramer shared his take, explaining that dot-com analogies do not hold up in this market. Cramer highlighted it as one of the “greatest American companies,” as he said:

…Let’s talk about some similarities that have now been popping up, okay? In 1999, we saw the wholesale slaughter of all the traditional growth stocks away from tech. It was tough to own any healthcare stock back then. We’re seeing something very similar now. I could give you a long list, but I’d rather just present to you… Abbott Labs, one of the greatest American companies in history. Abbott missed its last quarter by a smidge, and it’s now down 34% for the year. This is Abbott Labs, for heaven’s sake. A market that doles out such harsh punishment for Abbott Labs is a market that despises anything not connected to tech and the data center.

Stock market data. Photo by Jakub Zerdzicki on Pexels

Abbott Laboratories (NYSE:ABT) develops and sells healthcare products, including generic medicines, diagnostic systems, nutrition brands, cardiovascular and diabetes care devices, and neuromodulation technologies. Cramer discussed it as a part of his game plan during the April 10 episode and stated:

I also want to hear from Abbott Labs, and this is tricky, okay? Its stock’s down an astounding 20% for the year after that last just so-so quarter, and a loss and a lawsuit about its special baby formula. But I don’t know if this really, if this stock really belongs on the 52-week low list. I mean, that said, if Abbott’s going to go higher, it’s going to have to give us a couple of reasons on the call.

While we acknowledge the potential of ABT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years 

Disclosure: None. Follow Insider Monkey on Google News.